本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Aligos Therapeutics, Inc.

9.69
+0.19502.05%
盤後9.860.1750+1.81%19:55 EDT
成交量:5.30萬
成交額:51.39萬
市值:5,957.63萬
市盈率:-1.02
高:10.10
開:9.60
低:9.47
收:9.49
52周最高:46.80
52周最低:3.76
股本:615.14萬
流通股本:300.20萬
量比:0.71
換手率:1.76%
股息:- -
股息率:- -
每股收益(TTM):-9.4728
每股收益(LYR):-20.9448
淨資產收益率:-87.74%
總資產收益率:-40.30%
市淨率:0.58
市盈率(LYR):-0.46

資料載入中...

2025/08/07

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/08/06

重要事件披露

Form 8-K - Current report
2025/08/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/06/26

重要事件披露

Form 8-K - Current report
2025/05/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/06

重要事件披露

Form 8-K - Current report
2025/04/02

SEC問詢函

Form CORRESP - Correspondence
2025/03/10

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/10

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/10

重要事件披露

Form 8-K - Current report
2025/02/12

重要事件披露

Form 8-K - Current report
2025/02/03

重要事件披露

Form 8-K - Current report
2024/11/15

SEC問詢函

Form CORRESP - Correspondence
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/06

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans